Top

Current Clinical Trials

Let us know if  you or someone you know is interested in participating in one of the Actively Recruiting Clinical Trials:

Actively Recruiting

 DISCOVERY-PD  
Proteomics, Metabolomics, Lipidomics and Genetic Analysis for Biomarker DISCOVERY in Parkinson’s Disease 

◊ iSTEP
A Phase 3, 12-week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study to Evaluate the Efficacy of Oral Istradefylline 20 and 40 mg/day as Treatment for Subjects with Moderate to Severe Parkinson’s Disease 

◊ PPMI
The Parkinson’s Progression Markers Initiative 




Ongoing, But Not Actively Recruiting
◊ PD-SOAR 
A Prospective Randomized Placebo-Controlled Double-Blind Study Assessing Change in Olfactory Function After Initiation of Rasagiline in Idiopathic Parkinson's Disease  
◊ NET-PD LS-1
A Multicenter, Double-Blind, Parallel Group, Placebo Controlled Study of Creatine in Subjects with
Treated Parkinson's Disease. Long-term Study - 1 
◊ ACP-103-015
A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the
Treatment of Psychosis in Parkinson’s Disease
◊ NPF-QII
National Parkinson Foundation Quality Improvement Initiative
PARS
Parkinson Associated Risk Factor Study:  Evaluating Potential Screening Tools for Parkinson's disease 
 NIC-PD
A Randomized, Placebo-Controlled, Multi-Center Study to Assess the Disease Modifying Potential of Transdermal NICotine in Early Parkinson's Disease in Germany and the USA

 

675 Almanor Avenue | Sunnyvale, CA 94085
408.734.2800 main | 408.734.8455 fax (Main) | 408.734.9208 fax (Clinic Secure)